Intrinsic Value of S&P & Nasdaq Contact Us

LAVA Therapeutics N.V. LVTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • NL • USD

SharesGrow Score
51/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$6.00
+244.8%

LAVA Therapeutics N.V. (LVTX) — Analyst outlook / Analyst consensus target is. Based on 6 analyst ratings, the consensus is bullish — 2 Buy, 4 Hold.

The consensus price target is $6.00, representing an upside of 244.8% from the current price $1.74.

LVTX Stock — 12-Month Price Forecast

$6.00
▲ +244.83% Upside
Average Price Target
Based on 6 Wall Street analysts offering 12-month price targets for LAVA Therapeutics N.V., the price target is $6.00.
The average price target represents a +244.83% change from the last price of $1.74.

LVTX Analyst Ratings

Hold
6
Ratings
2 Buy
4 Hold
Based on 6 analysts giving stock ratings to LAVA Therapeutics N.V. in the past 3 months
Rating breakdown
Buy
2 33%
Hold
4 67%
33%
Buy
2 analysts
67%
Hold
4 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message